Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Capital Structure Change

Advanced Enzyme Technologies Capital Structure Change

Advanced Enzyme Technologies bought back 54,455 equity shares via Emkay Global on October 29, 2026 at an average of ₹263.76. Cumulative buyback stands at 24,10,906 shares under the ongoing open-market programme.

Key figures
Value₹1.44 Cr
Source

BSE filing, NSE: ADVENZYMES. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Advanced Enzyme Technologies Ltd: key numbers

Share price
₹266.00
Market cap
₹2,979 Cr
Revenue (annual)
₹745.8 Cr
Net profit (annual)
₹168.7 Cr
P/E (TTM)
18.0×Sector 46.1×
Promoter holding
43.56%+0.32% QoQ
FII holding
26.64%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Advanced Enzyme Technologies Ltd

All →

Other capital structure change announcements

All →